Trial · NCT04871711
Trial comparisons19
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 19 of 19
Download this page as JSON| Comparison | Source |
|---|---|
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Score (Weekly Average) of ≥4 Points From Baseline at Week 8 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Itch Score (Weekly Average) of ≥4 Points From Baseline at Week 8 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Itch Score (Weekly Average) of ≥4 Points From Baseline at Week 16 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Score (Weekly Average) of ≥4 Points From Baseline at Week 4 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With IGA-CHE TS at Week 8 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With HECSI-75 at Week 8 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With IGA-CHE TS at Week 4 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Reduction of DLQI Score of ≥4 Points From Baseline at Week 16 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Pain Score (Weekly Average) of ≥4 Points From Baseline at Week 16 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Score (Weekly Average) of ≥4 Points From Baseline at Week 16 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With HECSI-90 at Week 16 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Pain Score (Weekly Average) of ≥4 Points From Baseline at Week 4 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Itch Score (Weekly Average) of ≥4 Points From Baseline at Week 4 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Itch Score (Weekly Average) of ≥4 Points From Baseline at Week 2 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With IGA-CHE TS at Week 16 | Trial comparisons |
| Delgocitinib |20 mg/g vs Vehicle|: deaths from any cause | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With Reduction of HESD Pain Score (Weekly Average) of ≥4 Points From Baseline at Week 8 | Trial comparisons |
| Delgocitinib Cream 20 mg/g vs Cream Vehicle: Number of Participants With HECSI-75 at Week 16 | Trial comparisons |
| Delgocitinib |20 mg/g vs Vehicle|: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04871711/comparisons